|Professor of Medicine
Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center and the Leona M. and Harry B. Helmsley Charitable Inflammatory Bowel Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Jean-Frédéric Colombel has been the director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center since January 2013. Professor Colombel began his career at CHU de Lille, France in 1980 where he was Professor of Hepato-Gastroenterology from 1991, and Head of the Department of Gastroenterology from 2010 to 2012. Since 1984, his research has focused on IBD. Thanks to the development of multiple local, national and international collaborations, he has been able to contribute to important advances in the pathophysiology of IBD. Professor Colombel has trained several generations of fellows both in the US and in Europe, and many of them are now key opinion leaders in IBD in their respective countries. This leadership in IBD has been recognised and he was elected as the President of the European Crohn’s and Colitis Organisation (ECCO) (2008–2010) and Chair of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) (2010–2012). Professor Colombel was awarded the United European Gastroenterology Federation (UEGF) Research Prize in 2009 and the Crohn’s and Colitis Foundation (CCF) Clinical Research Award in 2014 and the Sherman Prize in 2018. The main concretisation of Professor Colombel’s work has been the publication as primary author or co-author of more than 960 peer-reviewed papers, most of them in the domain of IBD. Professor Colombel has been an associate editor of major gastroenterology journals including Gut, Alimentary Pharmacology and Therapeutics and Gastroenterology (current).
Asbjørn Mohr Drewes
|Current position, work address and ORCID: Professor and Chief Physician, Director of Mech-Sense and Centre for Pancreatic Diseases, Department of Gastroenterology & Hepatology, Aalborg University Hospital, Mølleparkvej 4, 9000 Aalborg. ORCID: https://orcid.org/0000-0001-7465-964X
Education: MD from Aarhus University 1983. Specialist in internal medicine and gastroenterology in 1997.
Degrees: Defended his PhD thesis at Aalborg University in 1998 and his doctoral thesis (DMSc) at Aarhus University in 1999. Received the European Diploma in Pain Medicine (EDPM) in 2017.
Main academic positions:
• Associate Professor from 1996
• Professor in visceral pain from 2003
• Full Professor (Chair) in Medicine & Gastroenterology from 2007
Scientific work: Although he has always been fully employed as clinician, he has authored 606 peer-reviewed articles, book chapters, and reviews and has an H-index of 55. He is a widely recognised expert in pancreatology, visceral pain, pharmacology, and brain-gut interactions. As such he is a frequent speaker and chairman at international congresses and has been organizer of many international meetings. Currently he is member of the scientific board of United European Gastroenterology, European Society of Neurogastroenterology and Motility, and the education board of European Federation of Pain. Since 2012 he has been the President of Scandinavian Association for Neurogastroenterology and Motility and chairs the Danish Pancreas Forum and the Scandinavian-Baltic Expert Forum and database. His primary research interests are chronic pancreatitis, gastrointestinal pain, brain-gut axis, motility pharmacology of analgesics, physiology of the gastrointestinal tract, clinical gastroenterological studies, imaging, and technology development. He serves as editorial board member for several journals, has participated in expert groups for the Danish Health and Medicines Authority, and is co-inventor of patents.
Grants and awards: He’s research have been funded from many different national and international foundations such as Karen Elise Jensen´s Foundation, The Obel Family Foundation, the Danish Agency for Science, Technology and Innovation and EU 7th Framework Programme (# 223630) and a research grant (#10-092786/DSF) offered by the Danish Agency for Science, Technology and Innovation. In December 2018 he received a grant (# NNF18OC0052045) from NovoNordisk Foundation with collaboration between 3 Danish University Hospitals, and in December 2019 received another grant from the same foundation (#NNF190C0057331). In total he personally raised about 12 MIO € in external funding for research since 2000, and an additional amount from collaborative research with other groups. He has been honored with awards from the Danish Association of Gastroenterology, The Muusfelt Foundation and Danish Association of Rehabilitation Medicine. He was assigned the prestigious “Hagedorn Prize” by Danish Association of Internal Medicine in 2018, and the “Generalkonsul Ernst Carlsens” Prize in 2020 by the Danish Medical Association. In May 2019 he was knighted (Order of the Dannebrog, R.) by Her Majesty Queen Margrethe II of Denmark.
Clinical and research management: He is a widely recognised expert in gastroenterology and pain, especially in diseases of pancreas and oesophagus. He has participated in more than 10 courses in management arranged by the Danish Medical Association. He holds the chair as Professor at Department of Gastroenterology and Hepatology with responsibility for budgets and quality control. In 2003 he co-founded and is now Director of Mech-Sense, which is a multidisciplinary research centre where he has the leadership of 20 co-workers (among them 8 Ph.D. students and 5 postdocs). He is also leader of the Clinical Trial Unit and the Centre for Pancreatic Diseases. He has outstanding experience as leader of research activities in-house as well as in multi-centre studies.
Supervisor duties, teaching, and experience as Principal Investigator: Has previously supervised 48 Ph.D. students and is currently supervisor for 11. He teaches medical students and students in health technology as well as postdocs and specialists within medicine, gastroenterology, pain, and pharmacology. He has participated in several GCP courses and was Principal Investigator in more than 60 studies (phase I, II and III) mainly within pain treatment and gastroenterology.
|Charlotte Hedin comes from Britain and did her medical training at Oxford University and then AT and ST- training in London, principally at the Royal London Hospital in Whitechapel. She earned her PhD in 2013 at King's College London ("Microbial, immunological, phenotypic and genetic markers of risk: Aspects of Crohn's diseases that are shared by unaffected siblings"). In 2013 she moved to Stockholm with her Swedish husband and three children, which soon became four children. After learning some Swedish she began her post as resident physician in gastroenterology at Karolinska University Hospital in 2014. Since 2017 she has held a clinical post-doc at Karolinska University Hospital and in addition was given a UEG "Rising Star" award. She is now the research head of the Karolinska Gut Group, leading the group members in the research of luminal gastroenterology. Since 2018 she has served as a committee member within ECCO. Her research focuses on the role of the gut microbiota in inflammatory bowel disease, and also how the gut microbiota affects the development and function of the human immune system in healthy and diseased individuals.|
|Séverine Vermeire obtained her MD degree at the KU Leuven in 1995 and a PhD at the same University in 2001 on “Genetic Polymorphisms and Serologic Markers in Inflammatory Bowel Disease”. She further trained at the Universidad Nacional de Asuncion, Paraguay (1993), at the Wellcome Trust Centre for Human Genetics , University of Oxford (1997-1998) UK and at the Montreal General Hospital (McGill University) in Canada (2000–2001). Since 2003 she is staff member at the Gastroenterology Department of the University Hospitals Leuven and is appointed Full Professor of Medicine at the KU Leuven. Since 2016, she is Head of the De-partment of Chronic Diseases, Metabolism & Ageing (CHROMETA) at the KU Leuven.
Dr Vermeire is actively involved as principle investigator in RCTs with new therapeutic com-pounds and has been lead investigator on several of these programs. Her scientific work resulted in more than 500 peer-reviewed articles so far and focusses on the role of the mi-crobiome and genetic susceptibility in IBD and on identifying predictive signatures of treat-ment response. Dr Vermeire participated in the International iCHOM consortium on devel-opment of Patient-Centered Outcomes for Inflammatory Bowel Disease.
She was awarded several grants including an Advanced H2020-European Research Council (ERC) Grant (2016-2021) and a VIB Grand Challenges project on microbiota modulation strat-egies in Inflammatory Bowel Diseases together with Professor Jeroen Raes (2018)
Séverine Vermeire was President of the European Crohn’s and Colitis Organisation (ECCO) from 2014-2016 and of the Belgian IBD Research & Development (BIRD) Group from 2011-2013